Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Manali Petrochemicals Limited (MANALIPETC.NS)
Chennai, IN
Established in 1986 and headquartered in Chennai, India, Manali Petrochemicals Limited (MPL) is a prominent manufacturer and global supplier of various petrochemical products. The company's core operations involve producing key chemical intermediates and end-products for diverse industrial applications across both Indian and international markets. MPL's extensive product line features propylene oxide, which serves as a vital raw material for propylene glycol and polyether polyols. It also manufactures a comprehensive array of polyols, encompassing flexible slabstock, cold cure, rigid, and elastomer grades. These polyols are essential components for industries such as automotive, refrigeration, temperature control, adhesives, sealants, coatings, furniture, and textiles. Furthermore, Manali Petrochemicals supplies propylene glycol, indispensable for the pharmaceutical, food, flavor, and fragrance sectors. Its offerings also include polyester resins, carbonless paper, and automotive consumables like brake fluids and anti-freeze solutions. The company provides propylene glycol mono methyl ether, a solvent widely used in paint, coating, and electronics manufacturing. Additionally, MPL produces Neuthane polyurethane cast elastomers, critical for applications ranging from anti-roll bars, limit stops, and material handling equipment to rollers, harvester components, idler wheels for tracked vehicles, and suspension bushings for buses, trucks, and high-performance automobiles. Beyond manufacturing, Manali Petrochemicals Limited also participates in trading activities, facilitates transactions, and offers business and project consulting services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +12.63% | +13.22% | +18.09% | +14.54% | -3.34% | -0.49% | +11.20% | -13.51% | -22.75% | +116.74% | +1,777.78% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%+14.0% ★ Q1'26: +27.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+344.7% ★ Q1'26: +168.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.9% Q1'26: -1.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.7% Q1'26: +5.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.1% Q1'26: +5.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.3% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.67× ★ Q1'26: 1.37× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2013 actual |
|---|---|
| Revenue |
5.22B
est: 6.99B (-25.3%)
|
| EBITDA |
438.38M
est: 1.15B (-62.0%)
|
| EBIT |
332.09M
est: 1.00B (-66.9%)
|
| Net Income |
273.16M
est: 575.06M (-52.5%)
|
| SGA |
354.43M
est: 233.64M (+51.7%)
|
| EPS |
1.59
est: 3.34 (-52.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| R. Chandrasekar | MD, Chief Executive Officer of MPL Group & Whole-Time Director | 12M | male |
| Gopala Rammohan Sridhar | Whole Time Director & Head of Plant Operations | 5M | male |
| Ganesh Sri Vignesh | Company Secretary & Compliance Officer | — | male |
| Shivaram Narayanan | Chief Operating Officer | — | male |
| Srishti Bathija | Chief Financial Officer | — | female |
| Sundar Saimani | Senior General Manager of Sales & Marketing and R&D | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MANALIPETC.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
